Loading...
Vitamin D and cardiometabolic disease risk: A RCT and cross-sectional study
Agbalalah, Tari
Agbalalah, Tari
Citations
Altmetric:
Advisors
Editors
Other Contributors
Affiliation
EPub Date
Publication Date
2017-01-30
Submitted Date
Collections
Files
Loading...
Thesis
Adobe PDF, 3.25 MB
Other Titles
Abstract
Given the strong evidence for a beneficial role of vitamin D in diabetes and CVD pathogenesis, and the prevalence of vitamin D deficiency, vitamin D supplementation has been advocated for the prevention of cardiometabolic disease. To provide information on the effects of 5,000IU (125µg) vitamin D3 on cardiometabolic risk, a double blind, RCT in a cohort of overweight and obese UK adult males with plasma 25(OH)D concentration < 75nmol/L for a duration of 8 weeks was conducted. To the best of my knowledge, this is the first RCT to investigate the effect of 5,000IU (125µg) vitamin D3 on cardiometabolic markers in vitamin D insufficient, non-hypertensive and non-diabetic overweight and obese adult males.
Citation
Agbalalah, T. (2017). Vitamin D and cardiometabolic disease risk: A RCT and cross-sectional study (Doctoral Dissertation). University of Chester, United Kingdom.
Publisher
University of Chester
Journal
Research Unit
DOI
PubMed ID
PubMed Central ID
Type
Thesis or dissertation
Language
en